Results 71 to 80 of about 5,197,064 (280)

Growth of children with Langerhans cell histiocytosis [PDF]

open access: yes, 1995
Conclusion: GH deficiency is not a common manifestation of LCH in childhood and GH provocation tests are only indicated when there is a poor or decelerating growth rate.
Egeler, R.M. (Maarten)   +3 more
core   +1 more source

Isolated Langerhans cell histiocytosis of the vulva: a case report and review of the literature [PDF]

open access: yes, 2018
Isolated Langerhans cell histiocytosis (LCH) of the female genital tract is very rare. A review of the literature revealed that only 15 cases of primary vulvar LCH have previously been published in the English literature.
Beer, Karl   +5 more
core  

Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture.

open access: yesJournal of Clinical Investigation, 1986
We have investigated the secretory function of cell suspensions from bone eosinophilic granulomas surgically collected in two patients with histiocytosis X.
F. Arenzana‐Seisdedos   +4 more
semanticscholar   +1 more source

Familial polyposis syndrome and achalasia in a young adult

open access: yesJPGN Reports, Volume 6, Issue 2, Page 166-169, May 2025.
Abstract We report the case of a 19‐year‐old White male diagnosed with familial adenomatous polyposis (FAP), Gardner's syndrome (GS) phenotype, status post total colectomy, who developed progressive dysphagia and weight loss. He was diagnosed with achalasia based on imaging and esophageal manometry.
Gabriella A. Lorusso Vivas   +2 more
wiley   +1 more source

Pulmonary langerhans cell granulomatosis (histiocytosis X)

open access: yesТуберкулез и болезни лёгких, 2014
Pulmonary Langerhans cell granulomatosis is a rare disease. Its causes are unknown and accurate data on its prevalence are lacking. This disease is characterized by the formation of lung tissue granulomas consisting of activated Langerhans cells ...
A. A. Sadovnikov, K. I. Panchenko
doaj  

Diagnostic problems and surgical treatment of histiocytosis X [PDF]

open access: yesMedicinski Glasnik, 2007
A 16-year-old boy, with swelling and pain in the left submandibular region was treated at the Clinic for Maxillofacial Surgery. The x-ray examination showed destructive bone lesion of the mandibulae left side and oval lesions on the left hand bone and ...
Alkhalil M, A. Redžić, A. Smajilagić
doaj  

Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant

open access: yesPediatric Pulmonology, Volume 60, Issue 5, May 2025.
ABSTRACT Objective We are presenting two individuals with biallelic C‐C chemokine receptor type 2 (CCR2) deficiency carrying the novel c.644C>T p.L215P variant, who presented with chronic respiratory symptoms during infancy and developed multiple diffuse cystic lesions during childhood.
Moritz Herkner   +16 more
wiley   +1 more source

Langerhans Cell Histiocytosis (LCH) and Diabetes Insipidus with Mandibular lesion

open access: yesElectronic Physician, 2012
Langerhans cell histicytosis (LCH) is a rare disorder that primarily affects children. Its occurrence in adult is very rare. We report a case of 42 year old female patient who presented polyuria and polydipsia, loosing teeth and diplopia added to symptom
Sayeh Alizad jahani   +3 more
doaj  

Clinical experience in an infant with Langerhans cell histiocytosis

open access: yesUniversidad Médica Pinareña, 2021
Introduction: Langerhans cell histiocytosis (LCH) or Histiocytosis X is a benign proliferative disease affecting dendritic cells. It presents a wide clinical spectrum, from isolated eosinophilic bone granuloma to multisystem involvement with multiple ...
Yamilka Pita Barrios   +2 more
doaj  

Frequency and Implications of High‐Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort

open access: yesClinical and Translational Science, Volume 18, Issue 5, May 2025.
ABSTRACT Pharmacogenomics remains underutilized in pediatric oncology, despite the existence of evidence‐based guidelines. Implementation of pharmacogenomics‐informed prescribing could improve medication safety and efficacy in pediatric oncology patients, who are at high risk of adverse drug reactions.
Claire Moore   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy